CATALOGO DEI PRODOTTI DELLA RICERCA

ZIPETO, Donato
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.982
EU - Europa 10.063
AS - Asia 9.887
SA - Sud America 994
AF - Africa 195
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 7
Totale 32.167
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.727
CN - Cina 4.413
RU - Federazione Russa 3.401
SG - Singapore 3.168
GB - Regno Unito 2.408
IT - Italia 1.185
BR - Brasile 804
VN - Vietnam 796
HK - Hong Kong 623
FR - Francia 586
DE - Germania 527
SE - Svezia 485
IE - Irlanda 475
FI - Finlandia 454
KR - Corea 274
UA - Ucraina 168
CA - Canada 148
IN - India 114
ID - Indonesia 82
NG - Nigeria 76
AR - Argentina 69
NL - Olanda 68
BE - Belgio 64
MX - Messico 63
TR - Turchia 63
BD - Bangladesh 61
JP - Giappone 53
PL - Polonia 44
IQ - Iraq 42
ZA - Sudafrica 41
AU - Australia 37
EC - Ecuador 34
AT - Austria 31
ES - Italia 31
LT - Lituania 28
UZ - Uzbekistan 23
PK - Pakistan 22
JO - Giordania 18
SA - Arabia Saudita 17
CL - Cile 16
CO - Colombia 16
RO - Romania 16
AE - Emirati Arabi Uniti 13
PY - Paraguay 13
VE - Venezuela 13
IR - Iran 12
MA - Marocco 12
PH - Filippine 12
PE - Perù 11
AZ - Azerbaigian 10
CH - Svizzera 10
CR - Costa Rica 10
EG - Egitto 10
KE - Kenya 10
BO - Bolivia 9
IL - Israele 9
TN - Tunisia 9
KZ - Kazakistan 8
NO - Norvegia 8
NP - Nepal 8
SI - Slovenia 8
TG - Togo 8
UY - Uruguay 8
DK - Danimarca 7
LB - Libano 7
HU - Ungheria 6
OM - Oman 6
AL - Albania 5
BG - Bulgaria 5
BJ - Benin 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
ET - Etiopia 5
EU - Europa 5
JM - Giamaica 5
LV - Lettonia 5
MY - Malesia 5
SN - Senegal 5
SV - El Salvador 5
TH - Thailandia 5
BY - Bielorussia 4
GR - Grecia 4
KG - Kirghizistan 4
PA - Panama 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
DO - Repubblica Dominicana 3
HN - Honduras 3
HR - Croazia 3
NI - Nicaragua 3
PT - Portogallo 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
EE - Estonia 2
GT - Guatemala 2
IS - Islanda 2
LK - Sri Lanka 2
LU - Lussemburgo 2
Totale 32.131
Salva come PNG Salva come JPEG
Città #
Southend 2.051
Singapore 1.696
Jacksonville 1.308
Moscow 1.121
Chandler 1.066
San Jose 1.038
Ashburn 989
Dallas 917
Verona 658
Hong Kong 611
Ann Arbor 481
Dublin 473
Woodbridge 456
Beijing 375
Houston 337
The Dalles 271
Council Bluffs 254
Ho Chi Minh City 245
New York 243
Wilmington 193
Los Angeles 191
Lawrence 185
Princeton 185
Nanjing 184
Hanoi 144
Jinan 137
Helsinki 127
Shenyang 115
Tianjin 98
Buffalo 95
Sindelfingen 90
Munich 89
São Paulo 81
Changsha 77
Dong Ket 74
Abuja 73
Boardman 73
Hebei 72
Milan 71
Orem 68
Nanchang 65
Ningbo 62
Redondo Beach 62
Haikou 61
Seattle 61
Zhengzhou 60
Hangzhou 58
Brussels 56
Jakarta 56
Columbus 53
Santa Clara 53
Montreal 52
London 50
Redmond 45
Da Nang 43
Seoul 43
Taizhou 43
Tokyo 42
Frankfurt am Main 41
Jiaxing 41
Cambridge 40
Guangzhou 40
Atlanta 37
Toronto 37
Lancaster 36
Warsaw 36
Taiyuan 34
Denver 32
Haiphong 31
Rio de Janeiro 31
Chennai 30
Redwood City 30
Johannesburg 28
Lappeenranta 28
Rome 28
San Francisco 28
Oxford 25
Stockholm 25
Turku 25
Amsterdam 24
Brooklyn 24
Norwalk 24
Kent 23
Chicago 22
Elora 22
Lanzhou 22
Vienna 22
Basingstoke 21
Bologna 21
Fuzhou 21
Phoenix 21
Mexico City 20
Falls Church 19
Nuremberg 19
Belo Horizonte 18
Mumbai 18
Poplar 18
San Diego 18
Shanghai 18
Tashkent 18
Totale 19.093
Salva come PNG Salva come JPEG
Nome #
CRISPR/Cas9 mediated knock-out of RUNX2 in melanoma cells 1.327
CRISPR/Cas9 genome editing in melanoma cells: new insight of RUNT domain 1.302
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines 364
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity 297
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 267
CRISPR/Cas9 as a tool for studying the interactions between viral and cellular proteins 267
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 244
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 244
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 240
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 239
Gα15 in early onset of pancreatic ductal adenocarcinoma 239
HLA-C increases HIV-1 infectivity by interacting with the envelope glycoprotein gp120 236
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 234
Human T-cell leukemia virus HBZ and APH-2 antisense proteins interaction with host factors and their involvement in NF-Kb activation 233
Testing the performance of the imputation of MHC region in large datasets when using different reference panels 232
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 232
Analysis of colorectal cancers for human cytomegalovirus presence 232
5. CRISPR/Cas9 for the Study of the Interactions between Viruses and Host 227
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 226
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 226
Analisi molecolare delle interazioni fra citomegalovirus umano e leucociti 221
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 219
A CRISPR/Cas9 based approach to study the implication of HTLV regulatory proteins in the NF-κB modulation. 218
2. CRISPR/Cas9 to study virus-host interactions 216
HLA-C associates with Env and Increases HIV-1 infectivity 214
P-D9 Human Thioesterase 8 and HIV-1 Nef interaction 214
Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays 214
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 214
A potential role of RUNX2- RUNT domain in modulating the expression of genes involved in bone metastases: an in vitro study with melanoma cells 214
Development of chimeric humanized monoclonal antibodies against HIV-1 213
CRISPR/Cas9 as a tool for the study of the interactions between viruses and host 213
Host-virus interactions: HTLV antisense regulatory proteins play a role in the dysregulation of NF-κB pathway 211
HLA-C increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41. 210
In silico structural prediction and in vitro functional validation to identify the ACOT8 regions involved in the interaction with HIV-1 Nef 208
Runx2 stimulates neoangiogenesis through the Runt domain in melanoma 208
Presence and role of HLA-C in HIV-1 infection 207
Studiare la regione HLA negli esomi 207
HTLV-1 and HTLV-2 Tax, HBZ and APH-2 interaction with host factors: their involvement in cellular pathways regulation. 206
HLA-C associates with Env and increases HIV-1 infectivity 204
The human T-cell leukemia virus -2 (HTLV-2) antisense protein APH-2 interacts with p65 and inhibits NF-ĸB Tax-2 activation. 204
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 202
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 201
Expression of a candidate vaccine for AIDS prevention in transgenic tobacco plants 199
Il ruolo di HLA-C nell'infezione da HIV-1 198
The Runt domain of RUNX2 induces the migration of melanoma cells to bone 198
HLA-C expression levels and binding stability to β2m are involved in HIV-1 infectivity 197
Detection and typing of Human Cytomegalovirus DNA in colorectal cancer 196
Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity 196
Association analysis between HIV-1 Env and HLAC using bimolecular fluorescence complementation 193
Influenza - Prous Science Integrity 192
Association Analysis Between HIV-1 Env and HLA-C Using Bimolecular Fluorescence Complementation 192
Dissection of HLA-C gene region to investigate its association with complex traits 189
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 188
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 188
HTLV ANTISENSE PROTEINS ROLE IN THE NF-κB MODULATION. 187
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 186
HIV-1 Env glycoprotein and HLA-C associate and increase HIV-1 infectivity 184
New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration 184
Induction of HIV-1 neutralizing antibodies by fusion complexes 183
Unsung hero Robert C. Gallo 181
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 181
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 179
HLA-C and HIV-1: a matter of stability 178
Production of a candidate HIV-1 vaccine in transgenic tobacco plants 177
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 177
Physical activity prevents cartilage degradation: a metabolomics study pinpoints the involvement of vitamin B6 177
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 176
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 175
New vaccine strategies for chronic viral infections 172
Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first? 170
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 169
NF-κB activation mediated by HTLV-1 transactivator Tax protein is impaired in TRAF3 knock-out cells. 168
Vectors derived from antibodies for transfecting substances into cells 167
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 167
HTLV deregulation of the NF-κB pathway: an update on tax and antisense proteins role 165
HTLV-1 BASIC LEUCIN ZIPPER FACTOR AND ITS HOMOLOGOUS APH-2 IMPAIR NF-κB ACTIVATION MEDIATED BY THE VIRAL ONCOPROTEIN TAX. 165
Vectors derived from antibodies for transferring substances into cells 164
Involvement of HLA-C binding stability to β2-microglobulin in HIV-1 infection 163
HLA-C stability and AIDS progression 163
HLA-C increases HIV-1 infectivity and is associated with gp120 162
CRISPR/Cas system: an emerging technology in stem cell research 162
Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity" 161
Delayed progression to AIDS in HTLV-I/HIV-1 coinfected intravenous drug users 160
TRAF3 involvement in the NF-κB pathway deregulation mediated by HTLV-1 Tax protein 160
Gelsolin activity controls efficient early HIV-1 infection 158
Expression and purification of recombinant HTLV-II Tax protein in E.Coli and mammalian cells 155
Cell-based vaccination: rationale for the use of cells co-expressing HIV anv gp120 and HLA class I Cw4 molecules for the induction of neutralizing antibodies 154
A fast and reliable method for detecting SNP rs67384697 (Hsa-miR-148a binding site) by a single run of allele-specific real-time PCR 154
ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19 154
Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma 151
TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins 150
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 147
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 147
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 146
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 145
Single-chain antibody fragments for transferring substance 143
Induction of human immunodeficiency virus (HIV) broad spectrum neutralizing antibodies with fusion complexes. 143
Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression 143
Increased prevalence of unstable HLA-C variants in HIV-1 rapid-progressor patients 142
A simple method for human cytomegalovirus (HCMV) DNA quantitation in clinical samples 141
Totale 21.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.067
article - articoli 42.341
book - libri 4.464
conference - conferenze 49.546
curatela - curatele 0
other - altro 0
patent - brevetti 1.205
selected - selezionate 0
volume - volumi 1.511
Totale 198.134
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 0 0 132
2021/20221.498 155 338 16 77 47 48 48 99 54 67 146 403
2022/20233.232 253 312 304 571 288 755 27 196 363 40 75 48
2023/20243.664 66 145 153 180 189 2.278 114 96 19 73 201 150
2024/20254.121 268 264 140 623 174 87 297 210 659 283 272 844
2025/202612.364 811 617 971 1.922 2.918 897 1.248 681 1.021 854 176 248
Totale 32.386